G B Migliori

Summary

Affiliation: Fondazione Salvatore Maugeri
Country: Italy

Publications

  1. pmc Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group
    G B Migliori
    Fondazione Salvatore Maugeri, Care and Research Institute, Tradate, Italy
    Bull World Health Organ 76:475-83. 1998
  2. pmc Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement
    Masoud Dara
    World Health Organization, Regional Office for Europe, Copenhagen, Denmark
    Eur Respir J 40:1081-90. 2012
  3. doi request reprint Drug-resistant tuberculosis
    Emanuele Pontali
    Department of Infectious Diseases, Galliera Hospital, Genova, Italy
    Curr Opin Pulm Med 19:266-72. 2013
  4. pmc European union standards for tuberculosis care
    G B Migliori
    WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, via Roncaccio 16, 21049 Tradate, Italy
    Eur Respir J 39:807-19. 2012
  5. pmc Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso
    Paolo Miotto
    Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milan, Italy
    BMC Infect Dis 9:142. 2009
  6. doi request reprint Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control
    Giovanni Battista Migliori
    WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute TBNET Secretariat TuBerculosis Network European Trialsgroup Stop TB Italy, via Roncaccio 16, 21049, Tradate, Italy
    Clin Chest Med 30:637-65, vii. 2009
  7. doi request reprint Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives
    Giovanni Battista Migliori
    WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, Tradate, Italy
    Curr Opin Pulm Med 16:171-9. 2010
  8. doi request reprint Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases
    G B Migliori
    WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, via Roncaccio 16, 21049, Tradate, Italy
    Eur Respir J 31:1155-9. 2008
  9. ncbi request reprint Microbiological confirmation of tuberculosis cases at diagnosis and at the end of treatment in Italy
    G B Migliori
    Fondazione Salvatore Maugeri, Clinica del Lavoro e della Riabilitazione, Care and Research Institute, Tradate, VA, Italy
    Eur J Epidemiol 16:719-24. 2000
  10. ncbi request reprint Clinical and operational value of the extensively drug-resistant tuberculosis definition
    G B Migliori
    WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, via Roncaccio 16, 21049, Tradate, Italy
    Eur Respir J 30:623-6. 2007

Collaborators

Detail Information

Publications37

  1. pmc Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group
    G B Migliori
    Fondazione Salvatore Maugeri, Care and Research Institute, Tradate, Italy
    Bull World Health Organ 76:475-83. 1998
    ..Decision-makers and health administrators should be responsible for re-investing the financial and human resources mobilized by the adoption of cost-effective strategies within the TB control programme...
  2. pmc Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement
    Masoud Dara
    World Health Organization, Regional Office for Europe, Copenhagen, Denmark
    Eur Respir J 40:1081-90. 2012
    ....
  3. doi request reprint Drug-resistant tuberculosis
    Emanuele Pontali
    Department of Infectious Diseases, Galliera Hospital, Genova, Italy
    Curr Opin Pulm Med 19:266-72. 2013
    ..This review discusses the recent evidence on epidemiology, diagnosis, and treatment of drug-resistant and multidrug-resistant (MDR) tuberculosis (TB), an area where solutions for better diagnosis and treatment continually develop...
  4. pmc European union standards for tuberculosis care
    G B Migliori
    WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, via Roncaccio 16, 21049 Tradate, Italy
    Eur Respir J 39:807-19. 2012
    ..These will support EU health programmes to identify and develop optimal procedures for TB care, control and elimination...
  5. pmc Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso
    Paolo Miotto
    Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milan, Italy
    BMC Infect Dis 9:142. 2009
    ....
  6. doi request reprint Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control
    Giovanni Battista Migliori
    WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute TBNET Secretariat TuBerculosis Network European Trialsgroup Stop TB Italy, via Roncaccio 16, 21049, Tradate, Italy
    Clin Chest Med 30:637-65, vii. 2009
    ..Adherence to internationally agreed standards of care and control practices is imperative to achieve TB control...
  7. doi request reprint Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives
    Giovanni Battista Migliori
    WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, Tradate, Italy
    Curr Opin Pulm Med 16:171-9. 2010
    ....
  8. doi request reprint Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases
    G B Migliori
    WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, via Roncaccio 16, 21049, Tradate, Italy
    Eur Respir J 31:1155-9. 2008
    ..As Mycobacterium tuberculosis drug resistance is increasing worldwide, there is an urgent need for novel interventions in the fight against tuberculosis...
  9. ncbi request reprint Microbiological confirmation of tuberculosis cases at diagnosis and at the end of treatment in Italy
    G B Migliori
    Fondazione Salvatore Maugeri, Clinica del Lavoro e della Riabilitazione, Care and Research Institute, Tradate, VA, Italy
    Eur J Epidemiol 16:719-24. 2000
    ..The importance of further disseminating national guidelines among physicians managing TB is emphasized, in order to achieve a higher proportion of TB cases bacteriologically confirmed at diagnosis and monitored at the end of treatment...
  10. ncbi request reprint Clinical and operational value of the extensively drug-resistant tuberculosis definition
    G B Migliori
    WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, via Roncaccio 16, 21049, Tradate, Italy
    Eur Respir J 30:623-6. 2007
    ....
  11. ncbi request reprint Surveillance of anti-tuberculosis drug resistance: results of the 1998/1999 proficiency testing in Italy. SMIRA (Italian Multicentre Study on Antituberculosis Drug Resistance) Study Group
    G B Migliori
    Fondazione S Maugeri, Clinica del Lavoro e della Riabilitazione, Care and Research Institute, Tradate, Italy
    Int J Tuberc Lung Dis 4:940-6. 2000
    ..To determine the accuracy of drug-susceptibility testing (DST) for isoniazid, rifampicin, ethambutol and streptomycin in a provisional network of 22 regional laboratories in Italy...
  12. ncbi request reprint A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
    G B Migliori
    WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, Tradate, Italy
    Eur Respir J 34:387-93. 2009
    ..Its safety profile does not warrant use in cases for which there are other, safer, alternatives...
  13. doi request reprint TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?
    G B Migliori
    WHO Collaborating Centre forTuberculosis and Lung Diseases, Fondazione S Maugeri, Care andReasearch Institute, Tradate, Italy
    Eur Respir J 39:619-25. 2012
    ..Training, increased awareness, promotion of standards and allocation of appropriate resources are necessary to ensure appropriate care and management as well as to prevent further emergence of drug resistance...
  14. ncbi request reprint Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000
    G B Migliori
    World Health Organization WHO Collaborating Centre for Tuberculosis and Lung Diseases, Dept of Pneumonology, S Maugeri Foundation, Care and Research Institute, Tradate, Italy
    Eur Respir J 21:129-34. 2003
    ..9 to 2%). The significant association found between isoniazid resistance and immigration is a useful indicator for both clinicians managing individual tuberculosis cases and public health services planning control strategies...
  15. ncbi request reprint Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool
    G B Migliori
    Fondazione S Maugeri, Care and Research Institute, World Health Organization Collaborating Centre for TB and Lung Diseases, Tradate, Italy
    Int J Tuberc Lung Dis 13:1305-8. 2009
    ..This GLC-endorsed tool supports global efforts to contain MDR/XDR-TB and is useful in developing national MDR/XDR-TB control strategies...
  16. ncbi request reprint First tuberculosis cases in Italy resistant to all tested drugs
    G B Migliori
    WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, Tradate, Italy
    Euro Surveill 12:E070517.1. 2007
  17. pmc Cost-comparison of different management policies for tuberculosis patients in Italy. AIPO TB Study Group
    G B Migliori
    Fondazione Salvatore Maugeri, Care and Research Institute, Tradate, Italy
    Bull World Health Organ 77:467-76. 1999
    ....
  18. doi request reprint The best on infections: update from the 2010 ERS Congress
    M Miravitlles
    Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Hospital Clinic, Ciber de enfermedades respiratorias CIBERES, Barcelona, Spain
    Eur Respir J 38:450-5. 2011
    ....
  19. ncbi request reprint Problems to control TB in eastern Europe and consequences in low incidence countries
    G B Migliori
    WHO Collaborating Centre for Tuberculosis and Lung Diseases, Pneumology Department, S Maugeri Foundation, IRCCS, via Roncaccio 16, 21049, Tradate, Varese, Italy
    Monaldi Arch Chest Dis 57:285-90. 2002
    ..As opportunities for improved funding of TB control in the region exist, there is the potential to reverse to TB pandemic before the explosion of the HIV epidemic expected in Eastern Europe...
  20. ncbi request reprint Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy
    G B Migliori
    WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate, Italy
    Int J Tuberc Lung Dis 6:858-64. 2002
    ..Ivanovo Oblast, Russian Federation, 300 km north-east of Moscow, where a pilot DOTS TB control programme was implemented in October 1995...
  21. ncbi request reprint Cost-effectiveness analysis of invasive and noninvasive tests in high risk patients treated with amiodarone after acute myocardial infarction
    R F Pedretti
    Fondazione Salvatore Maugeri, Care and Research Institute, Administrative Department, Rehabilitation Institute, Tradate, Italy
    J Am Coll Cardiol 31:1481-9. 1998
    ..noninvasive and electrophysiologic testing) on survival benefit and cost-effectiveness ratio of amiodarone therapy...
  22. ncbi request reprint Prevalence of resistance to anti-tuberculosis drugs: results of the 1998/99 national survey in Italy
    G B Migliori
    WHO Collaborating Centre for Control of Tuberculosis and Lung Diseases in Europe Department of Pnuemology, Tradate, Italy
    Int J Tuberc Lung Dis 6:32-8. 2002
    ....
  23. ncbi request reprint Evaluation of tuberculosis treatment results in Italy, report 1999
    R Centis
    WHO Collaborating Centre for Tuberculosis and Lung Diseases, Dept of Pneumology, Fondazione S Maugeri, Clinica del Lavoro e della Riabilitazione, Care and Research Institute, via Roncaccio 16, 21049, Tradate, VA, Italy
    Monaldi Arch Chest Dis 57:297-305. 2002
    ..A significantly higher percentage of deaths were recorded amongst native Italians (being age-related; p < 0.001) while immigrants had a higher default rate (p < 0.001)...
  24. ncbi request reprint 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic?
    G B Migliori
    Eur Respir J 29:423-7. 2007
  25. doi request reprint Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?
    G B Migliori
    Eur Respir J 31:904-5. 2008
  26. ncbi request reprint Management of multidrug-resistant tuberculosis in Italy
    G Ferrara
    Respiratory Diseases Section, University of Modena and Reggio Emilia, Modena, Italy
    Int J Tuberc Lung Dis 9:507-13. 2005
    ..SMIRA (Italian Study on Anti-Tuberculosis Drug Resistance) network, 46 major clinical units and 22 laboratories nationwide in Italy...
  27. ncbi request reprint Tuberculosis, one disease, many faces
    G B Migliori
    Monaldi Arch Chest Dis 69:2-4. 2008
  28. ncbi request reprint European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis As
    J F Broekmans
    Royal Netherlands Tuberculosis Association, The Hague, The Netherlands
    Eur Respir J 19:765-75. 2002
    ..g. through screening and bacille Calmette-Guéria immunization in specified groups), surveillance and treatment outcome monitoring are prerequisites to implementing the policy package recommended in this new framework document...
  29. ncbi request reprint Epidemiology and control of tuberculosis in Western European cities
    L R Codecasa
    Int J Tuberc Lung Dis 8:1275-6. 2004
  30. ncbi request reprint Comparison of tuberculin skin test and Quantiferon immunological assay for latent tuberculosis infection
    L R Codecasa
    Lombardia Region TB Reference Clinic and Laboratory, Villa Marelli Institute, Niguarda Hospital, Milano, Italy
    Monaldi Arch Chest Dis 63:158-62. 2005
    ..g. after BCG vaccination)...
  31. ncbi request reprint Use of commercial interferon-gamma assays in immunocompromised patients for tuberculosis diagnosis
    Federica Piana
    Am J Respir Crit Care Med 173:130; author reply 130-1. 2006
  32. ncbi request reprint Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients
    F Piana
    Emerging Bacterial Pathogens Unit, San Raffaele Turro, Via Stamira d Ancona 20, 20127 Milan, Italy
    Eur Respir J 28:31-4. 2006
    ..This study suggests that the T-SPOT.TB test maintains its sensitivity and performance in immunocompromised patients, identifying a large number of truly infected patients anergic to the tuberculin skin test...
  33. pmc Tuberculosis care and control
    Philip C Hopewell
    Bull World Health Organ 84:428. 2006
  34. ncbi request reprint Improving the TB case management: The International Standards for Tuberculosis Care
    G B Migliori
    Eur Respir J 28:687-90. 2006
  35. ncbi request reprint Ripped from the headlines: how can we harness communications to control TB?
    G B Migliori
    Eur Respir J 30:194-8. 2007
  36. ncbi request reprint External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countries
    L Fattorini
    Istituto Superiore di Sanita, Dipartimento di Malattie Infettive, Parassitarie e Immunomediate, Rome, Italy
    Int J Tuberc Lung Dis 12:214-7. 2008
    ..Quality assurance for the World Health Organization (WHO)/International Union Against Tuberculosis and Lung Disease (The Union) global tuberculosis (TB) drug resistance surveillance programme...
  37. pmc Survey of BCG vaccination policy in Europe: 1994-96
    L Trnka
    Tuberculosis Surveillance Unit, Clinic of Pneumology and Chest Surgery, University Hospital, Prague Bulovka, Czech Republic
    Bull World Health Organ 76:85-91. 1998
    ..Preventive methods whose cost-effectiveness has not been properly established should be discouraged...